Christopher Conn

Christopher Conn

Company: AbbVie

Job title: Director, Companion Diagnostics Strategy Lead


Strategies & Considerations for CDx Development in Early Phase Oncology Studies 11:30 am

• Best practices and key learnings from early CDx development • Aligning with the clinical development plan and timing of engagement with a diagnostic manufacturer • Understanding the prevalence of your biomarker and approaches for patient selection in Ph1 studiesRead more

day: Track C - Day 2 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.